New Key Statistics Module, Z-Score and F-Score
NYSE:ENZ Key Ratios
| Market Cap $ M | 38.03 |
| Enterprise Value $ M | -6.43 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.80 |
| Price/Sales | 1.23 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 30.00 |
| EPS (TTM) $ | -0.45 |
| Beneish M-Score | -2.88 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.83 |
| EV-to-EBITDA | 1.00 |
| PEG | -- |
| Shares Outstanding M | 52.24 |
| Net Margin (%) | -75.34 |
| Operating Margin % | -34.69 |
| Pre-tax Margin (%) | -23.79 |
| Quick Ratio | 2.28 |
| Current Ratio | 2.55 |
| ROA % (ttm) | -24.83 |
| ROE % (ttm) | -35.93 |
| ROIC % (ttm) | -31.68 |
| Dividend Yield % | 13.74 |
| Altman Z-Score | -4.05 |
ENZ Number of Guru Trades
ENZ Volume of Guru Trades
Gurus Latest Trades with NYSE:ENZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:ENZ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Enzo Biochem Inc Insider Transactions
No Available Data
News about NYSE:ENZ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers